| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.004 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.091 | 0.005 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.087 | 0.005 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.006 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.006 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.092 | 0.006 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.007 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.008 |